nach oben

Journal of Diabetes & Metabolic Disorders

Erschienen in:

15.01.2021 | Research article

The relationship between personality disorder, depression and eating disorder with treatment adherence in patients with type 2 diabetes; a cross-sectional study in diabetic patients in Iran

verfasst von: Negar Jalali, Habibeh Taghavi Kojidi, Rahim Badrfam, Atefeh Zandifar

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Adherence to treatment is of great importance in patients with diabetes mellitus due to its necessity and benefits. The purpose of this study was to evaluate the relationship between personality disorder, depression and eating disorder with appropriate treatment acceptance and follow-up in patients with type 2 diabetes.

Methods

This cross-sectional study was performed in Imam Ali Medical Education Center in Karaj city of Alborz province of Iran. A total of 1320 patients were evaluated and were screened according to the inclusion criteria, including type 2 diabetes and those over 18 years of age. Finally, considering the exclusion criteria, 600 patients with type 2 diabetes were included in the study. Patients were divided into 4 groups. 150 patients with type 2 diabetes in the control group, 150 patients with type 2 diabetes with major depressive disorder, 150 patients with type 2 diabetes with personality disorder and 150 patients with type 2 diabetes and eating disorder were studied. Questionnaires used in the study included Hamilton Depression Rating Scale(HAM-D) for depression, Minnesota Multiphasic Personality Inventory II (MMPI II) questionnaire for personality disorders and Eating Disorder Diagnostic Scale(EDDS) for eating disorder. The Murisky questionnaire also assessed adherence to treatment in patients, which included 8 questions. Scores measure the degree of adherence to treatment.

Results

600 patients with type 2 diabetes were studied. Patients were divided into 4 groups (each group consisting of 150 patients) of control, depression, personality disorder and eating disorder. Mean age, sex, marital status and duration of diabetes were not significantly different in the study groups (P > 0.05). The mean Murisky score in patients with depression and personality disorder was significantly lower than the control group (P < 0.05) but the mean Murisky score in patients with eating disorder was not significantly different (P > 0.05). Patients with depression, paranoid, schizotypal, antisocial, borderline, avoidant and dependent personality disorder had less adherent to treatment than the control group.

Conclusions

Early psychiatric evaluation of patients with diabetes and identification of possible disorders can help improve diabetes control.

Navipour E, et al. Predict of risk factors associated with diabetes type 2 by using logistic regression. 2017;12(2):59–65.

Kayedi M, et al. The associaty of chlamydia pneumoniae, helicobacter pylori herpes simplex virus type 1 and Cytomegalovirus in the northern Persian gulf population. ISMJ. 2015;18(1):135–46.

Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy: IV. Diabetic macular edema. Ophthalmology. 1984;91(12):1464–74.CrossRef

Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.CrossRef

Amini M, Parvaresh E. Prevalence of macro-and microvascular complications among patients with type 2 diabetes in Iran: a systematic review. Diabetes Res Clin Pract. 2009;83(1):18–25.CrossRef

Azizi Soleiman F, et al. The relationship between inflammation, oxidative stress, and metabolic risk factors in type 2 diabetic patients. Iranian J Diabetes Obesity. 2013;5(4):151–6.

Klein HA, Lippa KD. Assuming control after system failure: type II diabetes self-management. Cogn Tech Work. 2012;14(3):243–51.CrossRef

Balducci S, Sacchetti M, Haxhi J, Orlando G, D'Errico V, Fallucca S, et al. Physical exercise as therapy for type 2 diabetes mellitus. Diabetes Metab Res Rev. 2014;30(S1):13–23.CrossRef

Kaholokula, J.K.A., et al., Biological, psychosocial, and sociodemographic variables associated with depressive symptoms in persons with type 2 diabetes. J Behavior Med, 2003. 26(5): p. 435–458.

10.

Eskandari Khanghahi M, et al. Frequency of psychiatric and psychological disorders in patients with type II diabetes. J Mazandaran Univ Med Sci. 2017;27(155):37–45.

11.

Jokela M, Elovainio M, Nyberg ST, Tabák AG, Hintsa T, Batty GD, et al. Personality and risk of diabetes in adults: pooled analysis of 5 cohort studies. Health Psychol. 2014;33(12):1618–21.CrossRef

12.

Wisting L, et al. Adolescents with type 1 diabetes–the impact of gender, age, and health-related functioning on eating disorder psychopathology. PLoS One. 2015;10(11):e0141386.

13.

Papadopoulos AA, Kontodimopoulos N, Frydas A, Ikonomakis E, Niakas D. Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health. 2007;7(1):186.CrossRef

14.

Dunbar-Jacob J, Mortimer-Stephens M. Treatment adherence in chronic disease. J Clin Epidemiol. 2001;54(12):S57–60.CrossRef

15.

Chisholm-Burns MA, Spivey CA. The'cost'of medication nonadherence: consequences we cannot afford to accept. J Am Pharmacists Assoc. 2012;52(6):823–6.CrossRef

16.

Jack K, McLean SM, Moffett JK, Gardiner E. Barriers to treatment adherence in physiotherapy outpatient clinics: a systematic review. Man Ther. 2010;15(3):220–8.CrossRef

17.

Williams JB. A structured interview guide for the Hamilton depression rating scale. Arch Gen Psychiatry. 1988;45(8):742–7.CrossRef

18.

Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150(2):384–8.CrossRef

19.

Ebrahimi A, et al. Reliability, validity, factor and discrimination power analysis of young mania rating scale among unipolar, bipolar depression and healthy people. 2017;16(3):333–344.

20.

Butcher JN. Minnesota multiphasic personality inventory. The Corsini Encyclopedia of Psychology. 2010;1–3. https://doi.org/10.1002/9780470479216.corpsy0573.

21.

Dehghani M, et al. Standardization and psychometric properties of Minnesota Multiphasic Personality Inventory (MMPI-2). J Psych. 2010;14(3):299–318.

22.

Stice E, Telch CF, Rizvi SL. Development and validation of the eating disorder diagnostic scale: a brief self-report measure of anorexia, bulimia, and binge-eating disorder. Psychol Assess. 2000;12(2):123–31.CrossRef

23.

Khabir L, Mohamadi N, Rahimi C. The validation of eating disorder diagnostic scale (EDDS). J Kermanshah Univ Med Sci. 2014;18(2):100–7.

24.

Morisky DE. Predictive validity of a medication adherence measure for hypertension control. J Clin Hypertens. 2008;10:348–54.CrossRef

25.

Tan X, Patel I, Chang J. Review of the four item Morisky medication adherence scale (MMAS-4) and eight item Morisky medication adherence scale (MMAS-8). Innovations Pharm. 2014;5(3):5.CrossRef

26.

Ben AJ, Neumann CR, Mengue SS. The brief medication questionnaire and Morisky-green test to evaluate medication adherence. Revista de saude publica. 2012;46(2):279–89.CrossRef

27.

Al-Qazaz HK, et al. The eight-item Morisky medication adherence scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010;90(2):216–21.CrossRef

28.

Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item Morisky medication adherence scale (MMAS-8) in Iranian hypertensive patients. Global J Health Sci. 2015;7(4):173–83.CrossRef

29.

Zhang J, et al. Comparative study of the influence of diabetes distress and depression on treatment adherence in Chinese patients with type 2 diabetes: a cross-sectional survey in the People’s republic of China. Neuropsychiatr Dis Treat. 2013;9:1289.PubMed

30.

Zhang Y, Ting RZW, Yang W, Jia W, Li W, Ji L, et al. Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence: 中国人 2 型糖尿病抑郁情况及其与高血糖, 低血糖及治疗依从性关系的研究. J Diabetes. 2015;7(6):800–8.CrossRef

31.

Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398–403.CrossRef

32.

Niraula K, Kohrt BA, Flora MS, Thapa N, Mumu SJ, Pathak R, et al. Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal. BMC Psychiatry. 2013;13(1):309.CrossRef

33.

Egede LE, Dismuke CE. Serious psychological distress and diabetes: a review of the literature. Current Psychiatry Reports. 2012;14(1):15–22.CrossRef

34.

Kilbourne AM, Reynolds CF III, Good CB, Sereika SM, Justice AC, Fine MJ. How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry. 2005;13(3):202–10.CrossRef

35.

Maeda U, Shen BJ, Schwarz ER, Farrell KA, Mallon S. Self-efficacy mediates the associations of social support and depression with treatment adherence in heart failure patients. Int J Behavior Med. 2013;20(1):88–96.CrossRef

36.

Widiger TA and Costa Jr PT. Personality disorders and the five-factor model of personality. (3rd ed.). 2013: American Psychological Association. https://doi.org/10.1037/13939-000.

37.

Pollock-BarZiv SM, Davis C. Personality factors and disordered eating in young women with type 1 diabetes mellitus. Psychosomatics. 2005;46(1):11–8.CrossRef

38.

Kruisdijk F, Hopman-Rock M, Beekman ATF, Hendriksen IJM. Personality traits as predictors of exercise treatment adherence in major depressive disorder: lessons from a randomised clinical trial. Int J Psychiatry Clin Pract. 2020;24(4):380–6.CrossRef

39.

Nieto-Martínez R, González-Rivas JP, Medina-Inojosa JR, Florez H. Are eating disorders risk factors for type 2 diabetes? A systematic review and meta-analysis. Current Diabetes Reports. 2017;17(12):138.CrossRef

40.

Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160(21):3278–85.CrossRef

41.

Egede LE, Ellis C. Diabetes and depression: global perspectives. Diabetes Res Clin Pract. 2010;87(3):302–12.CrossRef

Titel: The relationship between personality disorder, depression and eating disorder with treatment adherence in patients with type 2 diabetes; a cross-sectional study in diabetic patients in Iran
verfasst von: Negar Jalali
Habibeh Taghavi Kojidi
Rahim Badrfam
Atefeh Zandifar
Publikationsdatum: 15.01.2021
Verlag: Springer International Publishing
Erschienen in: Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2021
Elektronische ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-020-00722-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Investigation of attitude, awareness, belief, and practice of complementary and alternative medicine among type 2 diabetic patients: a cross sectional study

Role of interdigital sensory nerve conduction study as a noninvasive approach for early diagnosis of diabetic peripheral neuropathy

Gene set enrichment analysis of PPAR-γ regulators from Murraya odorata Blanco

Cardiovascular diseases risk prediction in patients with diabetes: Posthoc analysis from a matched case-control study in Bangladesh

Awareness of influenza and pneumococcal vaccines in diabetic patients